Skip to main content
SpringerLink
Log in

Zielvolumenreduktion durch 18F-FDG-PET/CT-basierte „involved field“ Bestrahlung beim fortgeschrittenen NSCLC möglicherweise neuer Standard: Ergebnisse der PET-Plan-Studie

Target volume reduction by 18F-FDG-PET/CT-based involved-field irradiation of advanced non-small cell lung cancer possible new standard: results of the PET-plan study

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Nestle U et al (2020) Articles Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer ( PET-Plan ): a multicentre , open-label , randomised , controlled trial. Lancet Oncol. https://doi.org/10.1016/S1470-2045(20)30013-9

    Article  PubMed  Google Scholar 

  2. De Ruysscher D et al (2017) European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol 124:1–10

    Article  Google Scholar 

  3. Nestle U et al (2018) ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. Radiother Oncol 127:1–5

    Article  Google Scholar 

  4. Fleckenstein J, Kremp K, Kremp S, Palm J, Rübe C (2015) IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of pet-based treatment planning. Strahlenther Onkol 192:75–82

    Article  Google Scholar 

  5. Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY (2009) Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol 4(1):5. https://doi.org/10.1186/1748-717x-4-5

    Article  PubMed  PubMed Central  Google Scholar 

  6. Li R et al (2016) Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF). Radiat Oncol 11:124

    Article  Google Scholar 

  7. Nestle U et al (2015) Improved inter-observer agreement of an expert review panel in an oncology treatment trial—Insights from a structured interventional process. Eur J Cancer 51:2525–2533

    Article  Google Scholar 

  8. Schimek-Jasch T et al (2015) Verbesserung der Zielvolumendefinition durch einen Dummy Run mit interventionellem Konturierungstraining beim lokal fortgeschrittenen nicht-kleinzelligen Lungenkarzinom: Reduktion der Interobserver-Variabilität in klinischen Multizenterstudien. Strahlenther Onkol 191:525–533

    Article  Google Scholar 

  9. Schaefer A et al (2012) Multizentrische kalibrierung eines adaptiven schwellwertverfahrens zur PET-basierten volumen konturierung in der bestrahlungsplanung des lungenkarzinoms. Nuklearmedizin 51:101–110

    Article  CAS  Google Scholar 

  10. Bradley JD et al (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 16:187–199

    Article  CAS  Google Scholar 

  11. Schild SE et al (2019) Toxicity related to radiotherapy dose and targeting strategy: a pooled analysis of cooperative group trials of combined modality therapy for locally advanced non–small cell lung cancer. J Thorac Oncol 14:298–303

    Article  CAS  Google Scholar 

  12. MacHtay M et al (2012) Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. J Thorac Oncol 7:716–722

    Article  Google Scholar 

  13. Antonia SJ et al (2017) Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer. N Engl J Med 377:1919–1929

    Article  CAS  Google Scholar 

  14. Theurich S et al (2016) Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma. Cancer Immunol Res 4:744–754

    Article  CAS  Google Scholar 

  15. Demaria S, Coleman CN, Formenti SC (2016) Radiotherapy: changing the game in immunotherapy. Trends Cancer 2:286–294

    Article  Google Scholar 

  16. Deng L et al (2014) Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 124:687–695

    Article  CAS  Google Scholar 

  17. Buchwald ZS et al (2018) Radiation, immune checkpoint blockade and the abscopal effect: a critical review on timing, dose and fractionation. Front Oncol. https://doi.org/10.3389/fonc.2018.00612

    Article  PubMed  PubMed Central  Google Scholar 

  18. Theelen WS, de Jong MC, Baas P (2020) Synergizing systemic responses by combining immunotherapy with radiotherapy in metastatic non-small cell lung cancer: the potential of the abscopal effect. Cancer Treat Res 142:106–113

    Google Scholar 

  19. Golden EB, Demaria S, Schiff PB, Chachoua A, Formenti SC (2013) An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 1:365–372

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Fakultät, Klinikum rechts der Isar, Technische Universität München (TUM), Ismaninger Straße 22, 81675, München, Deutschland

    Denise Bernhardt

  2. Institut für Strahlenmedizin (IRM), Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Oberschleißheim, Deutschland

    Stephanie E. Combs

Authors
  1. Denise Bernhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie E. Combs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Denise Bernhardt.

Ethics declarations

Interessenkonflikt

D. Bernhardt und S.E. Combs geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Nestle U, Schimek-Jasch T, Kremp ST et al (2020) Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial. Lancet Oncol 21:581–592. DOI: https://doi.org/10.1016/S1470-2045(20)30013-9

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bernhardt, D., Combs, S.E. Zielvolumenreduktion durch 18F-FDG-PET/CT-basierte „involved field“ Bestrahlung beim fortgeschrittenen NSCLC möglicherweise neuer Standard: Ergebnisse der PET-Plan-Studie. Strahlenther Onkol 196, 743–746 (2020). https://doi.org/10.1007/s00066-020-01643-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-020-01643-7

Search

Navigation